Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center has participated in 5 clinical trials.
Therapeutic areas: Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer.
Sponsors: Puma Biotechnology, Inc., Gritstone bio, Inc., Clinigen, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center has 5 clinical trials on record. Their work covers Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer.
Yes — Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.